glp-1 oral drugs Comparing Ozempic, Wegovy and Other Injectable vs Oral GLP-1: Comparing
Description
One meta-analysis (April 2025) found no difference in incidence of aspiration (OR 1.04, 95% CI 0.871.25) despite the patients taking GLP-1 RAs having a higher incidence of residual gastric contents
[DOI] [PubMed] [Google Scholar] 69.Scrocchi LA, et al
95% CI 0.3, 1.7) or thyroid malignancies (RR 1.4
10.1093/eurheartj/ehp337 [DOI] [PubMed] 51.American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
However, early animal studies and lab research data show promise [81]
